US FDA pushes for new methods to replace animal testing in early drug studies

March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental drugs and adopt newer methods, such as computer ...

FDA finds little evidence that a drug touted by Trump can help people with autism

The Food and Drug Administation is approving a generic drug for a very rare genetic disorder, but not for autism.
Yahoo

FDA recall of blood pressure pills due to cancer-causing contaminant may point to higher safety risks in older generic drugs

Add Yahoo as a preferred source to see more of our stories on Google. Nitrosamines are by-products of many common chemical reactions. FatCamera/iStock via Getty Images Plus A generic blood pressure ...
CNN

FDA’s top drug officer set to exit, weeks into new role

The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was chosen to lead the FDA’s drug division, according to four people ...
Fox Business

FDA recalls blood pressure medication over cholesterol drug contamination

The U.S. Food and Drug Administration (FDA) issued a nationwide recall of thousands of bottles of blood-pressure medication last week after discovering cross-contamination with another drug.
FiercePharma

2025 approvals: Biopharma delivered 55 new drugs, biologics

How did staff layoffs, inspection backlogs and unprecedented leadership turnover affect the ability of the FDA to approve new drugs in 2025? While it would be presumptuous to base conclusions ...
The Baltimore Sun

FDA cracks down on weight-loss drug alternatives as thousands sickened in Maryland

Popular weight-loss drugs, including Ozempic, Wegovy, Trulicity and Mounjaro, produced by independent pharmacy labs, sickened some 8,000 or more Marylanders a year by 2024. The Food and Drug ...
Fox Business

Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats

Following threats from the Food and Drug Administration (FDA) that it would take "decisive" action against companies selling "illegal copycat drugs," telehealth company Hims & Hers announced it ...